The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

Xcellon Biologics will incorporate IntoCell’s OHPAS drug-linker system into its range of ADC development suites.

The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

Connect Biopharma Holdings Limited ( CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases November 3, 2025 4:15 PM EST ...

Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug ...